Ascletis Pharma (1672.HK) Q1 2025 Earnings

26MarConfirmed
Q1 2024
Q1 2024
Q3 2024
Q1 2025
-0.18
-0.15
-0.11
-0.08

Details

Expected EPS
-0.15974192639999998
Actual EPS
-0.18104084992
Surprise EPS
-0.02
Surprise Percent
+13.33%

Description

Ascletis Pharma (1672.HK) has reported earnings of -0.18104084992 per share for Q1 2025.

0 Comments

Share your thoughts